The 340B Drug Pricing Program, Hospital Prices, and Competition in Commercial Markets

What is known on this topic. The 340B Drug Pricing Program provides hospitals with significant drug discounts, but evidence of impacts on commercially insured patients is limited. Hospitals' incentives to share drug savings with insurers and patients may depend on how much competition they face...

Full description

Saved in:
Bibliographic Details
Published in:Health services research 2026-02, Vol.61 (1), p.e70085
Main Authors: Desai, Sunita M., Padmanabhan, Prianca, Smith, Kyle, Chang, Jessica, McWilliams, J. Michael
Format: Article
Language:English
Subjects:
Acute services
Charges
Claims
Clinical outcomes
Competition
Cost control
Costs
Discontinuity
Drug Costs - legislation & jurisprudence
Drug Costs - statistics & numerical data
Drug prices
Drugs
Economic Competition - economics
Economic Competition - statistics & numerical data
Eligibility
Enumeration
Health care expenditures
Health insurance
Health services
Hospital costs
Hospitals
Humans
Markets
Medical personnel
National plans
Patients
Pricing
Revenue
Thresholds
United States
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!